Diabetes, Vol 31, Issue 3 255-264, Copyright © 1982 by American Diabetes Association

ARTICLES

Comparison between continuous subcutaneous insulin infusion and multiple injections of insulin. A one-year prospective study

A Schiffrin and MM Belmonte

Twenty insulin-dependent diabetic patients participated in a 1-yr prospective randomized cross-over study comparing multiple subcutaneous injections (MSI) and continuous subcutaneous insulin infusion (CSII) complemented by home blood glucose monitoring. While 4 patients dropped out early, 16 patients completed the study. Patients had severe insulin deficiency documented by absent C-peptide response to glucagon stimulation. A marked improvement in control was observed when mean blood glucose and glycosylated hemoglobin A1 were compared with conventional therapy. No significant differences in the degree of metabolic control achieved, as measured by mean fasting, preprandial, and postprandial capillary blood glucose (CBG), M values, glycosylated hemoglobin A1 concentration, cholesterol and triglyceride levels were seen between MSI and CSII in the sixteen patients who completed the study. However, individual comparisons showed that fasting CBG and M-values were lower under CSII than MSI in seven patients (P less than 0.05). In contrast, two patients exhibited lower M values under MSI than under CSII (P less than 0.01), while for the remaining seven patients the results were similar. After completion of the study, two patients went back to conventional insulin therapy, seven patients remained on the pump, and seven patients chose to stay on MSI. In conclusion, on a long-term basis, the two methods can produce comparable levels of blood glucose and glycosylated hemoglobin in ambulatory insulin-dependent diabetics.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. T. Soliman, M. Omar, M. M. Rizk, A. El Awwa, and F. M. AlGhobashy Glycaemic Control with Modified Intensive Insulin Injections (MII) Using Insulin Pens and Premixed Insulin in Children with Type-1 Diabetes: A Randomized Controlled Trial J Trop Pediatr, August 1, 2006; 52(4): 276 - 281. [Abstract] [Full Text] [PDF]

				N. Weintrob, H. Benzaquen, A. Galatzer, S. Shalitin, L. Lazar, G. Fayman, P. Lilos, Z. Dickerman, and M. Phillip Comparison of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection Regimens in Children With Type 1 Diabetes: A Randomized Open Crossover Trial Pediatrics, September 1, 2003; 112(3): 559 - 564. [Abstract] [Full Text] [PDF]

				J. Pickup, M. Mattock, and S. Kerry Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials BMJ, March 23, 2002; 324(7339): 705 - 705. [Abstract] [Full Text] [PDF]

				J. Pickup and H. Keen Continuous Subcutaneous Insulin Infusion at 25 Years: Evidence base for the expanding use of insulin pump therapy in type 1 diabetes Diabetes Care, March 1, 2002; 25(3): 593 - 598. [Abstract] [Full Text] [PDF]

				M. J. Lenhard and G. D. Reeves Continuous Subcutaneous Insulin Infusion: A Comprehensive Review of Insulin Pump Therapy Arch Intern Med, October 22, 2001; 161(19): 2293 - 2300. [Abstract] [Full Text] [PDF]

				J. C. Boyd and D. E. Bruns Quality Specifications for Glucose Meters: Assessment by Simulation Modeling of Errors in Insulin Dose Clin. Chem., February 1, 2001; 47(2): 209 - 214. [Abstract] [Full Text] [PDF]

				E Barr and J. Leiden Systemic delivery of recombinant proteins by genetically modified myoblasts Science, December 6, 1991; 254(5037): 1507 - 1509. [Abstract] [PDF]

				M. M. Ulchaker and J. P. Sheehan Iatrogenic Brittle Diabetes: The Hold-the-Insulin Decision The Diabetes Educator, January 1, 1991; 17(2): 111 - 113. [PDF]

				J. S. Skyler Intensive Insulin Therapy: A Personal and Historical Perspective The Diabetes Educator, January 1, 1989; 15(1): 33 - 39. [PDF]